Ronald Blum
Internal Medicine · New York, NYNPI 1336122407
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $136,996 of the $137,051 with a category attached, or 100.0%. Merck accounts for 60.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $30,113 and has fallen 85.3% since, to $4,440 in 2025. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $2045.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$82K
- Bayer$23K
- Pfizer$20K
- Boehringer Ingelheim International GmbH$12K
- Incyte Corporation$55
Across 45 payments — averaging $3522.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$124K
- Boehringer Ingelheim International GmbH$16K
- Bayer$10K
- Ipsen Innovation$4K
- Biontech SE$3K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
What the payments were for
- Consulting fees$136,996100%
- Food & beverage$550%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 42 | $82,260 |
| Bayer | 16 | $22,515 |
| Pfizer | 3 | $20,471 |
| Boehringer Ingelheim International GmbH | 5 | $11,750 |
| Incyte Corporation | 1 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$26,500
- LENVIMA$25,263
- VYNDAQEL$20,471
- Non-Covered$12,825
- MK-7339$2,500
How this compares
$137,051 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in New York
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
- Terry PlasseNew York$883K
- Krisczar BungayNew York$554K
- Eytan SteinNew York$496K
- Larry NeumanNew York$457K
- Wuhua JingNew York$338K
- Harvey SchneienNew York$334K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.